Search results for: Health Care Systems
Filter search results
New Drugs to Tackle Antimicrobial Resistance: Breaking the European Deadlock: Part 1 – Defining Objectives
25 May 2023
…of the antibiotic. Value for money also means it should minimise the financial burden on health care systems to get the required antibiotics. De-link revenue from volume to allow for…
How to Analyse EQ-5D Data? Methods for Analysing and Reporting EQ-5D Data: The Indispensable New Guide
8 December 2020
…recently – in routine data collection in health care systems. (…) EQ-5D has become the cornerstone of health technology appraisal (HTA), affecting important decisions about access to new medicines. But despite…
The Impact of Health Technology Assessment on Drug Development
3 January 2009
…important snapshot of current industry perspectives on the impact of HTA. Responses show that the pharmaceutical industry is adjusting to the realities of today’s cost conscious health care systems by…
Hospital Acquired Infection
8 January 1997
…primary and secondary care. Given that many health care systems are changing, that lengths of stay are shrinking and that financial accountability is both more transparent and more stringent, it…
OHE Lunchtime Seminar on Pricing
15 April 2010
…biotechnology industries, consultancies, physicians’ associations, and government. The discussion focussed on value-based pricing for prescription medicines in both market and regulated systems, with comparisons of Sweden and the United States….
Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead
1 January 2020
…adult perspective (considering their own health) and EQ-5D-Y health states from a child perspective (considering the health of a 10-year-old child). Overall, respondents gave lower values under the adult perspective…
Migraine
1 September 1991
…does not shorten life or cause permanent injury. In contrast to many current health problems examined in the Office of Health Economics’ series, the morbidity generated by migraine does not…
Health Expenditure in the UK
1 May 1986
Share this: Download publication Robert Chew In the UK in 1984 the combined expenditure on health care services by both the public and private sectors rose to a record total…
Overview of the Economics of the Market for Medicines in the UK
29 March 2012
…His presentation covers the key issues, from drug development through health technology assessment and market access. Economics of the Market for Medicines in the UK from Office of Health Economics…